SDS Biotech K.K. announced consolidated earnings results for the nine months ended December 31, 2017. For the quarter, the company reported net sales of JPY 11,348 million as compared to JPY 10,828 million for the same period last year. Operating income was JPY 761 million as compared to JPY 577 million for the same period last year. Ordinary income was JPY 728 million as compared to JPY 442 million for the same period last year. Net profit attributable to owners of parent was JPY 335 million as compared to JPY 468 million for the same period last year. Net income per share was JPY 42.82 as compared to JPY 59.86 for the same period last year. Income before income taxes was JPY 724,769,000 compared to JPY 441,986,000 a year ago.

For the full year ending March 31, 2018, on consolidated basis, the company expects net sales of JPY 15,860 million, operating income of JPY 1,440 million, ordinary income of JPY 1,320 million, net income attributable to owners of parent of JPY 630 million and net income per share of JPY 80.45.

The company estimates to pay dividend of JPY 12.50 per share at the end of the fiscal 2018 against JPY 12.50 per share for the same period a year ago.